Kyung-Mi Kim

Title: Kyung-Mi Kim: Innovator in Therapeutic Compounds

Introduction

Kyung-Mi Kim is a notable inventor based in Sungnam, South Korea. She has made significant contributions to the field of therapeutic compounds, particularly in the development of novel chemical derivatives aimed at treating various medical conditions.

Latest Patents

Kyung-Mi Kim holds a patent for "N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses." This invention provides innovative N-alkyl-N-phenylhydroxylamine derivatives that contain metal chelating groups. The compounds are designed to be used therapeutically for treating and preventing medical dysfunctions and diseases that arise from reactive oxygen species (ROS) and excess zinc ions. These include serious conditions such as stroke, Parkinson's disease, and Alzheimer's disease. The compounds demonstrate similar or superior lipid peroxidation (LPO) inhibition activity compared to reference compounds like Trolox and Ebselen. They also exhibit lower toxicity while effectively inhibiting cerebral neuronal cell death caused by ROS and zinc ions, showcasing neuroprotective effects against ischemic neuronal degeneration.

Career Highlights

Kyung-Mi Kim is currently associated with Samsung Electronics Co., Ltd., where she continues to innovate and contribute to the field of therapeutic research. Her work has garnered attention for its potential impact on treating neurodegenerative diseases.

Collaborations

She has collaborated with notable colleagues, including Eu-Gene Oh and Sung-Bo Ko, to advance her research and development efforts.

Conclusion

Kyung-Mi Kim's innovative work in developing therapeutic compounds highlights her significant role in addressing critical medical challenges. Her contributions are paving the way for new treatments that could improve the quality of life for many individuals suffering from debilitating diseases.